Of note, as for the genetically unmodified target cells, no killing of the CD47 deleted cells occurred in the absence of the therapeutic antibody dinutuximab, demonstrating that CD47–SIRPα interactions only control antibody-dependent mechanisms of neuroblastoma killing by neutrophils. This evidence concerns the gene SIRPA and neuroblastoma.